"Overall, metabolic responses to glucagon stimulation in individuals with type 1 diabetes are comparable to those in healthy ...

The latest buzz around the popular weight loss drugs Ozempic, Mounjaro and Wegovy is to reduce the doseage to avoid the negative effects of normal doses. But does it have dangers too? Jessica Salter r ...

Novo Nordisk’s amycretin shows 22% weight loss over 36 weeks, potentially surpassing Eli Lilly’s Zepbound. Further trials are ...

On the other hand, when your blood sugar levels drop too low, your pancreas releases the hormone glucagon, which raises your ...

But when a person with diabetes has low blood sugar (hypoglycemia), their natural glucagon doesn’t work as well. If their blood sugar gets very low, they may get very sleepy, agitated, or confused or ...

Novo Nordisk has reported topline outcomes from a Phase Ib/IIa trial of amycretin designed for treating obese or overweight ...

The central and peripheral vascular haemodynamic effects of glucagon were studied in 29 patients. With a single dose method of 2 or 5 mg. glucagon intravenously the inotropic action of the drug ...

It is made in the pancreas. When blood sugars are low, glucagon tells the liver to send sugar into the blood, which goes to the cells for energy. When someone with diabetes has a very low blood sugar ...

Semaglutide combined with automated insulin delivery enhances glucose control in type 1 diabetes, lowering insulin ...

Results from Novo Nordisk's STEP UP trial show that a high-dose formulation of Wegovy can significantly increase the weight ...